Acute Kidney Injury and Extreme Rhabdomyolysis due to Carnitine Palmitoyltransferase II Deficiency: A Case Report.

J Emerg MedMar 8, 2026 (epub)

Elif Burma

✦ AI-curated · Sources linked

Case in brief

A 47-year-old man presented with influenza-like symptoms and rapidly developed extreme rhabdomyolysis, with creatine kinase >126,800 IU/L, dark urine, metabolic acidosis, multiorgan dysfunction, and acute kidney injury requiring renal replacement therapy. Continuous renal replacement therapy was started in intensive care, followed by gradual clinical improvement. A detailed family history led to genetic testing, which identified a homozygous pathogenic CPT2 mutation (p.Ser113Leu), confirming stress-induced myopathic carnitine palmitoyltransferase II deficiency.

What made this case unusual

An infectious-like illness preceded extreme rhabdomyolysis and severe acute kidney injury as the presenting manifestation of genetically confirmed CPT II deficiency in adulthood.

Diagnostic / clinical pearl

Consider an inherited metabolic myopathy when unexplained, extreme creatine kinase elevation and acute kidney injury occur, particularly alongside an infectious trigger; family history may help prompt genetic evaluation.

Source

Published in J Emerg Med. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Nephrology

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.